CNTB
Price
$1.58
Change
-$0.11 (-6.51%)
Updated
Sep 26 closing price
Capitalization
88.05M
KNTPF
Price
$0.26
Change
-$0.02 (-7.14%)
Updated
Sep 3 closing price
Capitalization
134.14M
Interact to see
Advertisement

CNTB vs KNTPF

Header iconCNTB vs KNTPF Comparison
Open Charts CNTB vs KNTPFBanner chart's image
Connect Biopharma Holdings
Price$1.58
Change-$0.11 (-6.51%)
Volume$92.55K
Capitalization88.05M
KINTOR PHARMACEUTICAL
Price$0.26
Change-$0.02 (-7.14%)
Volume$460
Capitalization134.14M
CNTB vs KNTPF Comparison Chart in %
Loading...
CNTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTB vs. KNTPF commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTB is a Hold and KNTPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (CNTB: $1.58 vs. KNTPF: $0.26)
Brand notoriety: CNTB and KNTPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTB: 65% vs. KNTPF: 93%
Market capitalization -- CNTB: $88.05M vs. KNTPF: $134.14M
CNTB [@Biotechnology] is valued at $88.05M. KNTPF’s [@Biotechnology] market capitalization is $134.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTB’s FA Score shows that 1 FA rating(s) are green whileKNTPF’s FA Score has 0 green FA rating(s).

  • CNTB’s FA Score: 1 green, 4 red.
  • KNTPF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CNTB and KNTPF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTB’s TA Score shows that 4 TA indicator(s) are bullish while KNTPF’s TA Score has 2 bullish TA indicator(s).

  • CNTB’s TA Score: 4 bullish, 4 bearish.
  • KNTPF’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, CNTB is a better buy in the short-term than KNTPF.

Price Growth

CNTB (@Biotechnology) experienced а +0.64% price change this week, while KNTPF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNTPF($134M) has a higher market cap than CNTB($88.1M). KNTPF YTD gains are higher at: 61.750 vs. CNTB (14.493).
CNTBKNTPFCNTB / KNTPF
Capitalization88.1M134M66%
EBITDA-47.66MN/A-
Gain YTD14.49361.75023%
P/E RatioN/AN/A-
Revenue1.97MN/A-
Total Cash71.8MN/A-
Total Debt870KN/A-
TECHNICAL ANALYSIS
Technical Analysis
CNTBKNTPF
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
38%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
33%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
34%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
56%
Advances
ODDS (%)
Bullish Trend 5 days ago
89%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
CNTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COVTY34.120.01
+0.03%
Covestro AG
USLIF0.01N/A
N/A
AMERICAN SALARS LITHIUM INC
BGAOF9.98N/A
N/A
Proximus Group
HCKG24.00N/A
N/A
Hocking Valley Bancshares, Inc. (OH)
HAOTF0.14N/A
N/A
HAO TIAN INTL CONSTR INVT GROUP LTD.

CNTB and

Correlation & Price change

A.I.dvisor tells us that CNTB and INKT have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTB and INKT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTB
1D Price
Change %
CNTB100%
-6.51%
INKT - CNTB
30%
Poorly correlated
+2.57%
ABCZF - CNTB
28%
Poorly correlated
N/A
XRTX - CNTB
27%
Poorly correlated
-6.98%
THAR - CNTB
25%
Poorly correlated
+3.78%
VERA - CNTB
23%
Poorly correlated
+4.60%
More

KNTPF and

Correlation & Price change

A.I.dvisor tells us that KNTPF and ICU have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNTPF and ICU's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNTPF
1D Price
Change %
KNTPF100%
N/A
ICU - KNTPF
22%
Poorly correlated
-1.00%
ATON - KNTPF
8%
Poorly correlated
-7.68%
CNTB - KNTPF
3%
Poorly correlated
-6.51%
BCTX - KNTPF
2%
Poorly correlated
+3.08%
LVTX - KNTPF
2%
Poorly correlated
+0.12%
More